Pl


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 18.9%
Nasopharyngitis 15.0%
Pyrexia 7.0%
Upper Respiratory Tract Inflammation 7.0%
Bronchitis 6.1%
Insomnia 5.8%
Hiv Infection 5.0%
Hypertension 5.0%
Gastritis 3.3%
Lower Respiratory Tract Infection 3.3%
Pneumonia 3.1%
Duodenal Ulcer Perforation 2.5%
Infection Prophylaxis 2.5%
Sedation 2.5%
Epidural Anaesthesia 2.2%
Osteoporosis 2.2%
Prophylaxis Of Nausea And Vomiting 2.2%
Upper Respiratory Tract Infection 2.2%
Hyperlipidaemia 1.9%
Influenza 1.9%
Interstitial Lung Disease 12.5%
Renal Failure Acute 8.9%
Loss Of Consciousness 7.1%
Renal Tubular Necrosis 7.1%
Hepatic Function Abnormal 5.4%
Musculoskeletal Stiffness 5.4%
Rash 5.4%
Upper Respiratory Tract Inflammation 5.4%
Lung Disorder 3.6%
Metrorrhagia 3.6%
Pancytopenia 3.6%
Rash Generalised 3.6%
Renal Failure 3.6%
Rhabdomyolysis 3.6%
Toxic Epidermal Necrolysis 3.6%
Urinary Retention 3.6%
Urticaria 3.6%
Vomiting 3.6%
White Blood Cell Count Decreased 3.6%
White Blood Cell Disorder 3.6%
Concomitant
Asthma 13.2%
Nasopharyngitis 12.4%
Gastritis 9.4%
Graft Versus Host Disease 7.1%
Hypertension 6.1%
Upper Respiratory Tract Inflammation 5.3%
Rheumatoid Arthritis 5.2%
Drug Use For Unknown Indication 5.1%
Chronic Obstructive Pulmonary Disease 4.9%
Multiple Myeloma 4.7%
Prophylaxis 4.4%
Bronchitis 4.1%
Insomnia 3.2%
Pyrexia 2.7%
Hiv Infection 2.6%
Immunosuppression 2.1%
Influenza 2.1%
Product Used For Unknown Indication 2.0%
Stomatitis 1.8%
Chronic Hepatitis C 1.6%
Pneumonia 13.0%
Vomiting 8.2%
Rhinorrhoea 7.7%
White Blood Cell Count Decreased 7.2%
Interstitial Lung Disease 5.8%
Renal Impairment 5.3%
Delirium 4.8%
Rhabdomyolysis 4.8%
Thrombocytopenia 4.8%
Rash 4.3%
Pulmonary Tuberculosis 3.9%
Pyrexia 3.9%
Stevens-johnson Syndrome 3.9%
Hepatic Function Abnormal 3.4%
Pneumocystis Jiroveci Pneumonia 3.4%
Tremor 3.4%
Urticaria 3.4%
White Blood Cell Count Increased 3.4%
Upper Respiratory Tract Inflammation 2.9%
Abnormal Behaviour 2.4%

Drug Data